Annons
Circio Holding logotypCircio Holding
20 november 2026 kl. 08:00(MFN)

Circio invites to live webcast on 27 November 2026 at 10:00 am CET

  • Circio management will provide an R&D and corporate update in a live webcast at 10:00am CET on Friday 27 November 2026
  • The webcast will include a summary of Circio's ESGCT 2026 presentations and advances in heart gene therapy program, including the collaboration with Solid Biosciences
  • New data demonstrating in vivo proof-of-concept for circVec in next-generation AAV capsids will also be presented

Oslo, Norway, 20 November 2026 – Circio Holding ASA (OSE: CRNA), a biotechnology company developing novel circular RNA expression technology for gene and cell therapy, will host a live webcast at 10:00am CET on Friday 27 November 2026.

In the webcast, CEO Dr. Erik D Wiklund will provide an overview of ongoing business development activities, including the recently announced collaboration with Solid Biosciences. CTO Dr. Thomas B Hansen will present the latest circVec pre-clinical gene therapy results, covering the heart program, new in vivo proof-of-concept data for circVec in next-generation AAV capsids and a summary of the oral presentation and two posters delivered at ESGCT 2026.

Presentation materials will be published ahead of the webcast on 27 November 2026.

The webcast will be held in English. Questions can be submitted in advance by email to Erik D Wiklund: erik.wiklund@circio.com or directly in the live webcast.

Time: 10:00 CET on Friday 27 November 2026

Click here to access Teams webcast
Meeting ID: 345 519 158 255 488 1
Passcode: g86R3cS9

A recording of the webcast will be made available on the Circio webpage and the presentation materials are attached hereto.

Källa: MFNMFN
Annons

0 kommentarer

Kommentera nyheten

När du kommenterar ett pressmeddelande publiceras din kommentar även i en speglad tråd under Börssnack så att alla i forumet kan delta i diskussionen!

Logga in eller skapa ett gratis konto för att kommentera nyheten!